These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18501602)

  • 1. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
    Perner RJ; Lee CH; Jiang M; Gu YG; Didomenico S; Bayburt EK; Alexander KM; Kohlhaas KL; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2803-7. PubMed ID: 15911258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.
    Kim S; Jung JK; Lee HS; Kim Y; Kim J; Choi K; Baek DJ; Moon B; Oh KS; Lee BH; Shin KJ; Pae AN; Nam G; Roh EJ; Cho YS; Choo H
    Bioorg Med Chem Lett; 2011 May; 21(10):3002-6. PubMed ID: 21489792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors.
    Wang S; Wood G; Meades C; Griffiths G; Midgley C; McNae I; McInnes C; Anderson S; Jackson W; Mezna M; Yuill R; Walkinshaw M; Fischer PM
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4237-40. PubMed ID: 15261277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
    Duval R; Kolb S; Braud E; Genest D; Garbay C
    J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
    [No Abstract]   [Full Text] [Related]  

  • 7. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
    Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of echiguanine analogs and their ribofuranosyl glycosides that inhibit phosphatidylinositol 4-kinase.
    Saito Y; Kato K; Umezawa K
    Nucleic Acids Symp Ser; 1997; (37):13-4. PubMed ID: 9585975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluation.
    Hughes TV; Emanuel SL; Beck AK; Wetter SK; Connolly PJ; Karnachi P; Reuman M; Seraj J; Fuentes-Pesquera AR; Gruninger RH; Middleton SA; Lin R; Davis JM; Moffat DF
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3266-70. PubMed ID: 17481894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
    J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
    Kempson J; Guo J; Das J; Moquin RV; Spergel SH; Watterson SH; Langevine CM; Dyckman AJ; Pattoli M; Burke JR; Yang X; Gillooly KM; McIntyre KW; Chen L; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
    Bioorg Med Chem Lett; 2009 May; 19(10):2646-9. PubMed ID: 19376699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
    Belema M; Bunker A; Nguyen VN; Beaulieu F; Ouellet C; Qiu Y; Zhang Y; Martel A; Burke JR; McIntyre KW; Pattoli MA; Daloisio C; Gillooly KM; Clarke WJ; Brassil PJ; Zusi FC; Vyas DM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4284-9. PubMed ID: 17540562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.
    Ren L; Laird ER; Buckmelter AJ; Dinkel V; Gloor SL; Grina J; Newhouse B; Rasor K; Hastings G; Gradl SN; Rudolph J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1165-8. PubMed ID: 22196124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
    Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
    ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New potential inhibitors of cyclin-dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation.
    Tu S; Zhang J; Zhu X; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3578-81. PubMed ID: 16621547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases.
    Bluhm U; Boucher JL; Buss U; Clement B; Friedrich F; Girreser U; Heber D; Lam T; Lepoivre M; Rostaie-Gerylow M; Wolschendorf U
    Eur J Med Chem; 2009 Jul; 44(7):2877-87. PubMed ID: 19144449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the herbicidal target IspD: allosteric site binding.
    Witschel MC; Höffken HW; Seet M; Parra L; Mietzner T; Thater F; Niggeweg R; Röhl F; Illarionov B; Rohdich F; Kaiser J; Fischer M; Bacher A; Diederich F
    Angew Chem Int Ed Engl; 2011 Aug; 50(34):7931-5. PubMed ID: 21766403
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.
    Crombie AL; Sum FW; Powell DW; Hopper DW; Torres N; Berger DM; Zhang Y; Gavriil M; Sadler TM; Arndt K
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3821-5. PubMed ID: 20471256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.